 | • レポートコード：MRC2-11QY12457 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は若年性黄斑変性症治療のグローバル市場について調査・分析したレポートです。種類別（アバシンカプタドペゴルナトリウム、エコーチオフェートヨウ化物、エミクススタト塩酸塩、FAB-111、その他）市場規模、用途別（クリニック、病院、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別若年性黄斑変性症治療の競争状況、市場シェア ・世界の若年性黄斑変性症治療市場：種類別市場規模 2015年-2020年（アバシンカプタドペゴルナトリウム、エコーチオフェートヨウ化物、エミクススタト塩酸塩、FAB-111、その他） ・世界の若年性黄斑変性症治療市場：種類別市場規模予測 2021年-2026年（アバシンカプタドペゴルナトリウム、エコーチオフェートヨウ化物、エミクススタト塩酸塩、FAB-111、その他） ・世界の若年性黄斑変性症治療市場：用途別市場規模 2015年-2020年（クリニック、病院、在宅医療） ・世界の若年性黄斑変性症治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、在宅医療） ・北米の若年性黄斑変性症治療市場分析：米国、カナダ ・ヨーロッパの若年性黄斑変性症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの若年性黄斑変性症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の若年性黄斑変性症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの若年性黄斑変性症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Acucela Inc.、Alkeus Pharmaceuticals Inc、Astellas Pharma Inc、Copernicus Therapeutics Inc、Grupo Ferrer Internacional SA、Iris Pharma、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Juvenile Macular Degeneration Treatment Market
The global Juvenile Macular Degeneration Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Juvenile Macular Degeneration Treatment Scope and Market Size
Juvenile Macular Degeneration Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Juvenile Macular Degeneration Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Acucela Inc.
Alkeus Pharmaceuticals Inc
Astellas Pharma Inc
Copernicus Therapeutics Inc
Grupo Ferrer Internacional SA
Iris Pharma
Sanofi
…
Market segment by Type, the product can be split into
Avacincaptad Pegol Sodium
Echothiophate Iodide
Emixustat Hydrochloride
FAB-111
Others
Market segment by Application, split into
Clinic
Hospital
Homecare
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Juvenile Macular Degeneration Treatment Revenue
1.4 Market by Type
1.4.1 Global Juvenile Macular Degeneration Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Avacincaptad Pegol Sodium
1.4.3 Echothiophate Iodide
1.4.4 Emixustat Hydrochloride
1.4.5 FAB-111
1.4.6 Others
1.5 Market by Application
1.5.1 Global Juvenile Macular Degeneration Treatment Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Juvenile Macular Degeneration Treatment Market Perspective (2015-2026)
2.2 Global Juvenile Macular Degeneration Treatment Growth Trends by Regions
2.2.1 Juvenile Macular Degeneration Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Juvenile Macular Degeneration Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Juvenile Macular Degeneration Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Juvenile Macular Degeneration Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Juvenile Macular Degeneration Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Juvenile Macular Degeneration Treatment Players by Market Size
3.1.1 Global Top Juvenile Macular Degeneration Treatment Players by Revenue (2015-2020)
3.1.2 Global Juvenile Macular Degeneration Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Juvenile Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Juvenile Macular Degeneration Treatment Market Concentration Ratio
3.2.1 Global Juvenile Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Juvenile Macular Degeneration Treatment Revenue in 2019
3.3 Juvenile Macular Degeneration Treatment Key Players Head office and Area Served
3.4 Key Players Juvenile Macular Degeneration Treatment Product Solution and Service
3.5 Date of Enter into Juvenile Macular Degeneration Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Juvenile Macular Degeneration Treatment Historic Market Size by Type (2015-2020)
4.2 Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
5.2 Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Juvenile Macular Degeneration Treatment Market Size (2015-2020)
6.2 Juvenile Macular Degeneration Treatment Key Players in North America (2019-2020)
6.3 North America Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
6.4 North America Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Juvenile Macular Degeneration Treatment Market Size (2015-2020)
7.2 Juvenile Macular Degeneration Treatment Key Players in Europe (2019-2020)
7.3 Europe Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
7.4 Europe Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
8 China
8.1 China Juvenile Macular Degeneration Treatment Market Size (2015-2020)
8.2 Juvenile Macular Degeneration Treatment Key Players in China (2019-2020)
8.3 China Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
8.4 China Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Juvenile Macular Degeneration Treatment Market Size (2015-2020)
9.2 Juvenile Macular Degeneration Treatment Key Players in Japan (2019-2020)
9.3 Japan Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
9.4 Japan Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Juvenile Macular Degeneration Treatment Market Size (2015-2020)
10.2 Juvenile Macular Degeneration Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
11 India
11.1 India Juvenile Macular Degeneration Treatment Market Size (2015-2020)
11.2 Juvenile Macular Degeneration Treatment Key Players in India (2019-2020)
11.3 India Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
11.4 India Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Juvenile Macular Degeneration Treatment Market Size (2015-2020)
12.2 Juvenile Macular Degeneration Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
12.4 Central & South America Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Acucela Inc.
13.1.1 Acucela Inc. Company Details
13.1.2 Acucela Inc. Business Overview
13.1.3 Acucela Inc. Juvenile Macular Degeneration Treatment Introduction
13.1.4 Acucela Inc. Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020))
13.1.5 Acucela Inc. Recent Development
13.2 Alkeus Pharmaceuticals Inc
13.2.1 Alkeus Pharmaceuticals Inc Company Details
13.2.2 Alkeus Pharmaceuticals Inc Business Overview
13.2.3 Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Introduction
13.2.4 Alkeus Pharmaceuticals Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
13.2.5 Alkeus Pharmaceuticals Inc Recent Development
13.3 Astellas Pharma Inc
13.3.1 Astellas Pharma Inc Company Details
13.3.2 Astellas Pharma Inc Business Overview
13.3.3 Astellas Pharma Inc Juvenile Macular Degeneration Treatment Introduction
13.3.4 Astellas Pharma Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
13.3.5 Astellas Pharma Inc Recent Development
13.4 Copernicus Therapeutics Inc
13.4.1 Copernicus Therapeutics Inc Company Details
13.4.2 Copernicus Therapeutics Inc Business Overview
13.4.3 Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Introduction
13.4.4 Copernicus Therapeutics Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
13.4.5 Copernicus Therapeutics Inc Recent Development
13.5 Grupo Ferrer Internacional SA
13.5.1 Grupo Ferrer Internacional SA Company Details
13.5.2 Grupo Ferrer Internacional SA Business Overview
13.5.3 Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Introduction
13.5.4 Grupo Ferrer Internacional SA Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
13.5.5 Grupo Ferrer Internacional SA Recent Development
13.6 Iris Pharma
13.6.1 Iris Pharma Company Details
13.6.2 Iris Pharma Business Overview
13.6.3 Iris Pharma Juvenile Macular Degeneration Treatment Introduction
13.6.4 Iris Pharma Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
13.6.5 Iris Pharma Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Juvenile Macular Degeneration Treatment Introduction
13.7.4 Sanofi Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
13.7.5 Sanofi Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Juvenile Macular Degeneration Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Juvenile Macular Degeneration Treatment Revenue
Table 3. Ranking of Global Top Juvenile Macular Degeneration Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Juvenile Macular Degeneration Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Avacincaptad Pegol Sodium
Table 6. Key Players of Echothiophate Iodide
Table 7. Key Players of Emixustat Hydrochloride
Table 8. Key Players of FAB-111
Table 9. Key Players of Others
Table 10. Global Juvenile Macular Degeneration Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Juvenile Macular Degeneration Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Juvenile Macular Degeneration Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Juvenile Macular Degeneration Treatment Market Share by Regions (2015-2020)
Table 14. Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Juvenile Macular Degeneration Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Juvenile Macular Degeneration Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Juvenile Macular Degeneration Treatment Players
Table 21. Global Juvenile Macular Degeneration Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Juvenile Macular Degeneration Treatment Market Share by Players (2015-2020)
Table 23. Global Top Juvenile Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Juvenile Macular Degeneration Treatment as of 2019)
Table 24. Global Juvenile Macular Degeneration Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Juvenile Macular Degeneration Treatment Product Solution and Service
Table 27. Date of Enter into Juvenile Macular Degeneration Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Juvenile Macular Degeneration Treatment Market Size Share by Type (2015-2020)
Table 31. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Juvenile Macular Degeneration Treatment Market Size Share by Application (2015-2020)
Table 33. Global Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Juvenile Macular Degeneration Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Juvenile Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Juvenile Macular Degeneration Treatment Market Share (2019-2020)
Table 37. North America Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 39. North America Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Juvenile Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Juvenile Macular Degeneration Treatment Market Share (2019-2020)
Table 43. Europe Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 45. Europe Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Juvenile Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Juvenile Macular Degeneration Treatment Market Share (2019-2020)
Table 49. China Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 51. China Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Juvenile Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Juvenile Macular Degeneration Treatment Market Share (2019-2020)
Table 55. Japan Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 57. Japan Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Juvenile Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Juvenile Macular Degeneration Treatment Market Share (2019-2020)
Table 61. Southeast Asia Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Juvenile Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Juvenile Macular Degeneration Treatment Market Share (2019-2020)
Table 67. India Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 69. India Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Juvenile Macular Degeneration Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Juvenile Macular Degeneration Treatment Market Share (2019-2020)
Table 73. Central & South America Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 77. Acucela Inc. Company Details
Table 78. Acucela Inc. Business Overview
Table 79. Acucela Inc. Product
Table 80. Acucela Inc. Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 81. Acucela Inc. Recent Development
Table 82. Alkeus Pharmaceuticals Inc Company Details
Table 83. Alkeus Pharmaceuticals Inc Business Overview
Table 84. Alkeus Pharmaceuticals Inc Product
Table 85. Alkeus Pharmaceuticals Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 86. Alkeus Pharmaceuticals Inc Recent Development
Table 87. Astellas Pharma Inc Company Details
Table 88. Astellas Pharma Inc Business Overview
Table 89. Astellas Pharma Inc Product
Table 90. Astellas Pharma Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 91. Astellas Pharma Inc Recent Development
Table 92. Copernicus Therapeutics Inc Company Details
Table 93. Copernicus Therapeutics Inc Business Overview
Table 94. Copernicus Therapeutics Inc Product
Table 95. Copernicus Therapeutics Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 96. Copernicus Therapeutics Inc Recent Development
Table 97. Grupo Ferrer Internacional SA Company Details
Table 98. Grupo Ferrer Internacional SA Business Overview
Table 99. Grupo Ferrer Internacional SA Product
Table 100. Grupo Ferrer Internacional SA Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 101. Grupo Ferrer Internacional SA Recent Development
Table 102. Iris Pharma Company Details
Table 103. Iris Pharma Business Overview
Table 104. Iris Pharma Product
Table 105. Iris Pharma Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 106. Iris Pharma Recent Development
Table 107. Sanofi Company Details
Table 108. Sanofi Business Overview
Table 109. Sanofi Product
Table 110. Sanofi Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (Million US$)
Table 111. Sanofi Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Juvenile Macular Degeneration Treatment Market Share by Type: 2020 VS 2026
Figure 2. Avacincaptad Pegol Sodium Features
Figure 3. Echothiophate Iodide Features
Figure 4. Emixustat Hydrochloride Features
Figure 5. FAB-111 Features
Figure 6. Others Features
Figure 7. Global Juvenile Macular Degeneration Treatment Market Share by Application: 2020 VS 2026
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Homecare Case Studies
Figure 11. Juvenile Macular Degeneration Treatment Report Years Considered
Figure 12. Global Juvenile Macular Degeneration Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Juvenile Macular Degeneration Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Juvenile Macular Degeneration Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Juvenile Macular Degeneration Treatment Market Share by Players in 2019
Figure 17. Global Top Juvenile Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Juvenile Macular Degeneration Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Juvenile Macular Degeneration Treatment Revenue in 2019
Figure 19. North America Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
若年性黄斑変性症（シュタルガルト病）治療の世界市場（～2026年） Macular degeneration is a group of eye disease commonly found among children and adults. There are various types of macular degeneration affecting the teens such as Cone-Rod Dystrophy, Best disease, Stargardt disease, Corneal Dystrophy, and Fuch’s Dystrophy. Asia Pacific is expected to be the fastes…- 加齢黄斑変性症（AMD）遺伝子治療の世界市場（～2026年） Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- 黄斑変性症（AMD）の世界市場（～2026年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. The North American region is the most lucrative market, ow…
- 黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬の世界市場（～2026年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…
- 加齢性黄斑変性症の世界市場（～2026年） Market Analysis and Insights: Global Age-related Macular Degeneration Market The global Age-related Macular Degeneration market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Age-related Macular Degeneration Scope and Market…